Lung Function in Relation to Surgery, Anaesthesia, and Intensive Care

2020 ◽  
pp. 737-749
Author(s):  
Göran Hedenstierna
Keyword(s):  
1987 ◽  
Vol 3 (1) ◽  
pp. 29-33 ◽  
Author(s):  
I. Arad ◽  
E. Bar-Yishay ◽  
F. Eyal ◽  
S. Gross ◽  
S. Godfrey

Neurosurgery ◽  
2010 ◽  
Vol 66 (5) ◽  
pp. 925-932 ◽  
Author(s):  
Edward W. Swanson ◽  
Justin Mascitelli ◽  
Michael Stiefel ◽  
Eileen MacMurtrie ◽  
Joshua Levine ◽  
...  

Abstract OBJECTIVE Transport of critically ill intensive care unit patients may be hazardous. We examined whether brain oxygen (brain tissue oxygen partial pressure [PbtO2]) is influenced by transport to and from a follow-up head computed tomography (transport head computed tomography [tHCT]) scan. METHODS Forty-five patients (24 men, 21 women; Glasgow Coma Scale score ≤8; mean age, 47.3 ± 19.0 years) who had a traumatic brain injury (n = 26) or subarachnoid hemorrhage (n = 19) were retrospectively identified from a prospective observational cohort of PbtO2 monitoring in a neurosurgical intensive care unit at a university-based level I trauma center. PbtO2, intracranial pressure, and cerebral perfusion pressure were monitored continuously and compared during the 3 hours before and after 100 tHCT scans. RESULTS The mean PbtO2 before and after the tHCT scans for all 100 scans was 37.9 ± 19.8 mm Hg and 33.9 ± 17.2 mm Hg, respectively (P = .0001). A decrease in PbtO2 (>5%) occurred after 54 tHCTs (54%) and in 36 patients (80%). In instances in which a decrease occurred, the average decrease in mean, minimum, and maximum PbtO2 was 23.6%, 29%, and 18.1%, respectively. This decrease was greater when PbtO2 was compromised (<25 mm Hg) before tHCT. An episode of brain hypoxia (<15 mm Hg) was identified in the 3 hours before tHCT in 9 and after tHCT in 19 instances. On average, an episode of brain hypoxia was 46.6 ± 16.0 (standard error) minutes longer after tHCT than before tHCT (P = .008). Multivariate analysis suggests that changes in lung function (PaO2/fraction of inspired oxygen [FiO2] ratio) may account for the reduced PbtO2 after tHCT (parameter estimate 0.45, 95% confidence interval: 0.024–0.871; P = .04). CONCLUSION These data suggest that transport to and from the intensive care unit may adversely affect PbtO2. This deleterious effect is greater when PbtO2 is already compromised and may be associated with lung function.


Author(s):  
Aaron M. Cheng ◽  
Michael S. Mulligan ◽  
Kei Togashi

Lung transplantation is a widely accepted surgical procedure for treatment of select patients suffering from end-stage lung disease. Recipients, however, require meticulous post-transplant care to preserve allograft lung function and to ensure optimal patient quality of life. In the post-operative period, these patients are predisposed to specific complications and pose unique considerations that clinicians caring for these patients in the intensive care setting should be familiar with managing. This chapter focuses on the early post-operative critical care management of the lung transplant recipient with specific emphasis on hemodynamic resuscitation; early lung graft dysfunction; and considerations regarding immunosuppression and infection. Non-pulmonary issues that affect the clinical care of these patients in the ICU setting are also discussed.


1995 ◽  
Vol 19 (2) ◽  
pp. 118-128 ◽  
Author(s):  
Andrew H. Numa ◽  
Christopher J. L. Newth

2015 ◽  
Vol 79 (3-4) ◽  
Author(s):  
Biagio Polla

We present a case of a 85-year-old man who suffered from several chronic obstructive pulmonary disease (COPD) related exacerbations and hospitalizations. Traditional therapy, which also included intramuscular steroid therapy, did not help and caused several drug related adverse events. After yet another exacerbation followed by hospitalization at the intensive care unit, it was decided to start roflumilast treatment. In the year after beginning treatment, the patient did not experience any more exacerbations and his lung function also improved, as recorded by the COPD assessment test (CAT) score and improved forced expiratory volume in the first second (FEV1) value. In this patient roflumilast seems to be effective in reducing exacerbations, an important goal to be achieved in COPD patients.


1994 ◽  
Vol 77 (4) ◽  
pp. 2042-2047 ◽  
Author(s):  
W. P. Holland ◽  
W. Boender ◽  
J. A. Bos ◽  
P. E. Huygen

A simple and compact flow calibrator has been devised for generating precise predetermined constant flow rates for checking the calibration of laboratory and clinical flow transducers used in respiratory measurements. The standard version delivers preset flows of 0.5 and 1 l/s, whereas a tuned-up version can produce preset flows of 2.5 and 5 l/s, with an accuracy of +/- 2%. The pressure generated is sufficient to cope with most commonly used respiratory flowmeters. The flow calibrator is built from inexpensive components that are readily obtainable: a fan, a turbine flowmeter, and a feedback circuit in a compact housing. The device is easy to connect to other equipment and to operate. Three flow calibrators have been built and are in regular use in a lung function laboratory and on intensive care wards.


Sign in / Sign up

Export Citation Format

Share Document